13F Data
13F filer · CIK 1958125

Catalio Capital Management, LP

NEW YORK, NY · filing since Q4 2024 · last filing Sep 2, 2026
Reported value
$532.1M
+$53.4M vs prior
Positions
39
New / sold out
11 / 13
Added / reduced
15 / 8
Turnover
45.9%
buys $232.0M · sells $257.2M
Top-10 weight
56.7%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewAVALYN PHARMACEUTICALS INC+1,675,830–+$55.2M
NewJNJJOHNSON & JOHNSON+138,946–+$35.3M
NewPARABILIS MEDICINES INC+824,043–+$22.6M
AddedGILEAD SCIENCES INC+105,404+64.3%+$13.3M
NewPROTAGONIST THERAPEUTICS INC+106,799–+$13.1M
NewAXSOME THERAPEUTICS INC.+43,182–+$10.6M
NewKAILERA THERAPEUTICS INC+468,750–+$10.3M
NewODYSSEY THERAPEUTICS INC+457,839–+$8.6M
NewASCENDIS PHARMA A/S+31,759–+$8.5M
AddedSEPTERNA INC+241,792+82.1%+$8.1M
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedDIANTHUS THERAPEUTICS INC-527,367-94.1%$-51.4M
Sold outASCENDIS PHARMA A/S-129,111-100.0%$-29.5M
ReducedDEFINIUM THERAPEUTICS INC-475,312-45.8%$-22.4M
Sold outTERNS PHARMACEUTICALS INC-409,031-100.0%$-21.6M
Sold outSOLENO THERAPEUTICS INC-577,808-100.0%$-19.3M
Sold outBOSTON SCIENTIFIC CORP-299,318-100.0%$-18.8M
ReducedULTRAGENYX PHARMACEUTICAL IN-534,545-62.8%$-17.8M
ReducedVERADERMICS INC-127,726-73.6%$-15.7M
Sold outCYTOKINETICS INC-215,501-100.0%$-14.2M
Sold outADAPTIVE BIOTECHNOLOGIES COR-722,784-100.0%$-10.0M
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2024: $457.1MQ1 2025: $411.1MQ2 2025: $476.9MQ3 2025: $540.9MQ4 2025: $565.8MQ1 2026: $478.7MQ2 2026: $532.1M
Q4 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1AVALYN PHARMACEUTICALS INCCOM SHS1,675,830$55.2M10.37%
2JNJJOHNSON & JOHNSON138,946$35.3M6.63%
3GILEAD SCIENCES INCCOM269,309$34.0M6.39%
4BRIDGEBIO PHARMA INCCOM455,041$33.9M6.37%
5SYNDAX PHARMACEUTICALS INCCOM1,215,698$26.6M4.99%
6DEFINIUM THERAPEUTICS INCCOM SHS562,672$26.5M4.97%
7BRISTOL-MYERS SQUIBB COCOM412,961$23.8M4.47%
8PARABILIS MEDICINES INCCOM824,043$22.6M4.24%
9NATERA INCCOM82,181$22.3M4.19%
10INCYTE CORPCOM191,627$21.7M4.08%
29 more rows. Subscribe for $29/month to see every row, download the data and use the API.